Titan Pharmaceuticals Valuation
| TTNP Stock | USD 7.01 0.31 4.23% |
At this time, the company appears to be overvalued. Titan Pharmaceuticals has a current Real Value of $6.5 per share. The regular price of the company is $7.01. Our model measures the value of Titan Pharmaceuticals from inspecting the company fundamentals such as Current Valuation of 497.74 K, return on equity of -1.39, and Shares Owned By Insiders of 45.46 % as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Titan Pharmaceuticals' valuation include:
Price Book 0.9994 | Enterprise Value 497.7 K | Enterprise Value Ebitda (0.06) | Price Sales 36.0725 | Enterprise Value Revenue 443.338 |
Overvalued
Today
Please note that Titan Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Titan Pharmaceuticals is based on 3 months time horizon. Increasing Titan Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Titan Pharmaceuticals is useful when determining the fair value of the Titan stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Titan Pharmaceuticals. Since Titan Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Titan Stock. However, Titan Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.01 | Real 6.5 | Target 7.0 | Hype 6.9 |
The real value of Titan Stock, also known as its intrinsic value, is the underlying worth of Titan Pharmaceuticals Company, which is reflected in its stock price. It is based on Titan Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Titan Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Titan Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Titan Pharmaceuticals helps investors to forecast how Titan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Titan Pharmaceuticals more accurately as focusing exclusively on Titan Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Titan Pharmaceuticals' intrinsic value based on its ongoing forecasts of Titan Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Titan Pharmaceuticals' closest peers. When choosing an evaluation method for Titan Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Titan Pharmaceuticals Investments |
|
Titan Valuation Trend
Knowing Titan Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Titan Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Titan Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Titan Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Titan Market Cap
Titan Pharmaceuticals is rated fifth in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 6.81 Billion. Titan Pharmaceuticals adds roughly 6.41 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Titan Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Titan Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Titan Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Titan Pharmaceuticals competition to find correlations between indicators driving Titan Pharmaceuticals's intrinsic value. More Info.Titan Pharmaceuticals is rated third in price to earning category among related companies. It is rated third in price to book category among related companies . As of 04/23/2024, Price To Book Ratio is likely to drop to 0.89. Comparative valuation analysis is a catch-all model that can be used if you cannot value Titan Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Titan Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Titan Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Titan Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Titan Pharmaceuticals and how it compares across the competition.
About Titan Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Titan Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Titan Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Titan Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Titan Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Titan Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Titan Pharmaceuticals. We calculate exposure to Titan Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Titan Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 72 K | 68.4 K | |
| Pretax Profit Margin | (30.27) | (31.78) | |
| Operating Profit Margin | (39.55) | (41.53) | |
| Net Loss | (30.27) | (31.78) | |
| Gross Profit Margin | 0.39 | 0.37 |
8 Steps to conduct Titan Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Titan Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Titan Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Titan Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Titan Pharmaceuticals' revenue streams: Identify Titan Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Titan Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Titan Pharmaceuticals' growth potential: Evaluate Titan Pharmaceuticals' management, business model, and growth potential.
- Determine Titan Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Titan Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Titan Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Titan Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 752 K | |
| Shares Float | 700 K |
Titan Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Titan Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Titan we look at many different elements of the entity such as Titan's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Titan Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Titan Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Titan Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Titan Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Titan Pharmaceuticals' worth.When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.